$T2 Biosystems(TTOO.US)$ 10% Shareholder CR Group L.P. sold 13.13 million shares of Common Stocks on Sep 27, 28, 2023 at an average price of $0.173 for a total value of $2.27 million.
This transaction involves other related parties: CRG Partners III L.P., CRG Partners III - Parallel Fund (A) L.P., CRG Partners III (Cayman) Unlev AIV I L.P. and CRG Partners III (Cayman) Lev AIV I L.P..
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.